TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement for completion of dispatch of Postal Ballot Notice TORRENT PHARMACEUTICALS LTD. - 500420 - Notice Of Postal Ballot
In furtherance of our intimation dated 29th July, 2022 and in terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith copy of the Postal Ballot Notice. In compliance with the relevant circulars issued by Ministry of Corporate Affairs, the said Notice has already been sent through electronic mode to those members whose e-mail IDs are registered with the Company/ Depositories as on Friday, 29th July, 2022, being the cut-off date. TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Conference call with Analysts / Investors on Financial Results for the quarter ended 30th June, 2022 TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 
Results Earnings Call for Q1FY23 of Torrent Pharmaceuticals
Conference Call with Torrent Pharmaceuticals Management and Analysts on Q1FY23 Performance and Outlook. Listen to the full earnings transcript. TORRENT PHARMACEUTICALS LTD. - 500420 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Torrent Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here TORRENT PHARMACEUTICALS LTD. - 500420 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Declaration of Results of Voting Torrent Pharma consolidated net up 7 per cent at Rs 354 crore in Q1
The India business grew by 14 per cent powered by the top brands